Literature DB >> 24264180

Low plasma Chromium in patients with coronary artery and heart diseases.

M Simonoff1, Y Llabador, C Hamon, A M Peers, G N Simonoff.   

Abstract

Plasma chromium concentrations have been determined for 150 patients. These were subjected to coronary artery cineangiography and thereby divided into three groups: group CAD (those with coronary artery disease), group HD (those with heart disease, but no CAD) and group N (those with no CAD and no HD). Weighted, average chromium levels for these groups were 1.05, 1.72, and 8.51 ng/mL, respectively. The distributions of plasma chromium levels for the three groups suggest that an upper limit for plasma chromium may be established (6 ng/mL in this work) beyond which CAD may be considered to be extremely unlikely, thus eliminating the need for a certain number of cineangiographic examinations.

Entities:  

Year:  1984        PMID: 24264180     DOI: 10.1007/BF02989260

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  18 in total

1.  Effects and metabolism of glucose tolerance factor.

Authors:  W Mertz
Journal:  Nutr Rev       Date:  1975-05       Impact factor: 7.110

2.  The direct determination of serum chromium by an atomic absorption spectrophotometer with a heated graphite atomizer.

Authors:  R S Pekarek; E C Hauer; R W Wannemacher; W R Beisel
Journal:  Anal Biochem       Date:  1974-05       Impact factor: 3.365

3.  The role of chromium in mammalian nutrition.

Authors:  H A Schroeder
Journal:  Am J Clin Nutr       Date:  1968-03       Impact factor: 7.045

4.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

5.  Chromium and insulin in young subjects with normal glucose tolerance.

Authors:  V J Liu; R P Abernathy
Journal:  Am J Clin Nutr       Date:  1982-04       Impact factor: 7.045

6.  Comparisons of chromium status in diabetic and normal men.

Authors:  M B Rabinowitz; S R Levin; H C Gonick
Journal:  Metabolism       Date:  1980-04       Impact factor: 8.694

7.  Flameless atomic absorption spectroscopy of plasma chromium.

Authors:  D A Thompson
Journal:  Ann Clin Biochem       Date:  1980-05       Impact factor: 2.057

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Serum chromium in patients with recent and old myocardial infarction.

Authors:  A S Abraham; M Sonnenblick; M Eni; O Shemesh; A P Batt
Journal:  Am Heart J       Date:  1980-05       Impact factor: 4.749

10.  Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.

Authors:  O Gedik; S Unal; Z Koray
Journal:  Isr J Med Sci       Date:  1980-08
View more
  3 in total

1.  The isolation of glucose tolerance factors from brewer's yeast and their relation to chromium.

Authors:  M Simonoff; D Shapcott; S Alameddine; M T Sutter-Dub; G Simonoff
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

2.  Hair chromium levels in patients with vascular diseases.

Authors:  B X Huang; S Q Lin; S Y Chen; G Zhou; F Yin; Z P Lou; M M Bi
Journal:  Biol Trace Elem Res       Date:  1991-05       Impact factor: 3.738

3.  Chromium content of normal and pathologically altered lung tissue.

Authors:  G Wirnsberger; O Wawschinek; F Pruegger; H Hoefler
Journal:  Biol Trace Elem Res       Date:  1987-10       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.